Imagine quitting smoking with just one session. A new study from Johns Hopkins University shows that a single dose of psilocybin — the active compound in magic mushrooms — gave people six times better odds of ditching cigarettes than standard nicotine patches.
That's pretty wild, right? Even the study's lead author, Matthew Johnson, a psychiatry professor at Johns Hopkins, admitted he was surprised by how effective it was.
How it worked
The trial involved 82 smokers. Everyone got 13 weeks of counseling. But here's the kicker: one group used nicotine patches, and the other received a single, high dose of pure psilocybin in a guided session. Picture this: participants relaxing in a room with eye shades, listening to soft music. Facilitators were there to make sure everyone was comfortable.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News Detox
Six months later, the results were clear. Seventeen people in the psilocybin group had successfully quit. Only four people from the nicotine patch group could say the same. That's a huge difference. This means 70% of people using patches often go back to smoking. This new approach offers a serious alternative.
Now, this initial trial didn't have a placebo group. It's tough to hide the effects of a psychedelic. But the good news? The National Institutes of Health (NIH) is already funding a larger study that will include a placebo group. So, more definitive answers are on the way.
A new kind of reset button
Most current smoking cessation medicines target nicotine. They either replace it or mimic its effects. But psilocybin works totally differently. It seems to help the brain talk to itself in new ways. Think of it as a perspective shift, almost like hitting a reset button.
Participants reported feeling a new sense of control. They felt like they could finally break old patterns. Dr. Brian Barnett, an addiction psychiatrist not involved in the study, pointed out that it's not just the drug. The intensive therapy around the psilocybin session is key. It helps people learn and change after the experience.
This isn't just about smoking either. Psilocybin is also showing promise for alcohol dependence. Another compound, ibogaine, is getting attention for opioid use disorder. It's been over two decades since we've had a truly new way to help people quit smoking. This research could be a real game-changer for public health.
With a larger, more diverse trial now underway, we're about to learn even more about how this powerful approach works. It's exciting to see new tools emerging to tackle some of our biggest health challenges.
